Filing metadata

Accession number
0001127602-20-026750
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Oct 09, 2020
Reporting period
Oct 07, 2020
Description
Insider transaction

Explore SEC Filings Hub